Client 1st Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
WAM
CRM
Client 1st Advisory Group's LLY Position: Q2 2026 in Review
Client 1st Advisory Group increased its Eli Lilly (LLY) stake by 6.7% in Q2 2026, buying an estimated $109K and bringing the position to 1,705 shares worth $2.05M. The position accounts for 0.53% of the portfolio, ranked #33.
Client 1st Advisory Group first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 1,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Client 1st Advisory Group held 1,705 shares of Eli Lilly worth $2.05M as of Q2 2026.
- Client 1st Advisory Group bought 107 Eli Lilly shares in Q2 2026, an estimated $109K.
- Eli Lilly made up 0.53% of Client 1st Advisory Group's portfolio in Q2 2026, its #33 holding.
- Client 1st Advisory Group first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
- 1,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Client 1st Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.